Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armelle Luscan

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Medecine Sciences : M/S|December 12, 2018
[SUMMIT: a basket study scores points]Armelle Luscan, Éric Pasmant
Journal of Neuro-Oncology|June 29, 2013
Relevance of MPNST cell lines as models for NF1 associated-tumorsEric Pasmant, Armelle Luscan, Jennifer Varin, et al.
Medecine Sciences : M/S|September 2, 2014
[PRC2 alterations in NF1-associated malignant peripheral nerve sheath tumors: schwann cells with no complex]Armelle Luscan, Dominique Vidaud, Nicolas Ortonne, et al.
Experimental and Molecular Pathology|March 20, 2012
Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samplesAudrey Didelot, Delphine Le Corre, Armelle Luscan, et al.
Frontiers in Genetics|October 13, 2022
Case Report: How whole-genome sequencing-based cell-free DNA prenatal testing can help identify a marker mhromosomePascale Kleinfinger, Marie Brechard, Armelle Luscan, et al.
Genes, Chromosomes & Cancer|January 27, 2017
Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumorsPierre Sohier, Armelle Luscan, Angharad Lloyd, et al.
Journal of Medical Genetics|May 24, 2014
Mutations in SETD2 cause a novel overgrowth conditionArmelle Luscan, Ingrid Laurendeau, Valérie Malan, et al.
Genes|November 11, 2022
Noninvasive Prenatal Screening for Trisomy 21 in Patients with a Vanishing TwinPascale Kleinfinger, Armelle Luscan, Léa Descourvieres, et al.
European Journal of Human Genetics : EJHG|July 31, 2014
Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?Eric Pasmant, Béatrice Parfait, Armelle Luscan, et al.
Human Mutation|August 6, 2013
NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experienceAudrey Sabbagh, Eric Pasmant, Apolline Imbard, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Medecine Sciences : M/S|December 12, 2018
[SUMMIT: a basket study scores points]Armelle Luscan, Éric Pasmant
Journal of Neuro-Oncology|June 29, 2013
Relevance of MPNST cell lines as models for NF1 associated-tumorsEric Pasmant, Armelle Luscan, Jennifer Varin, et al.
Medecine Sciences : M/S|September 2, 2014
[PRC2 alterations in NF1-associated malignant peripheral nerve sheath tumors: schwann cells with no complex]Armelle Luscan, Dominique Vidaud, Nicolas Ortonne, et al.
Experimental and Molecular Pathology|March 20, 2012
Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samplesAudrey Didelot, Delphine Le Corre, Armelle Luscan, et al.
Frontiers in Genetics|October 13, 2022
Case Report: How whole-genome sequencing-based cell-free DNA prenatal testing can help identify a marker mhromosomePascale Kleinfinger, Marie Brechard, Armelle Luscan, et al.
Genes, Chromosomes & Cancer|January 27, 2017
Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumorsPierre Sohier, Armelle Luscan, Angharad Lloyd, et al.
Journal of Medical Genetics|May 24, 2014
Mutations in SETD2 cause a novel overgrowth conditionArmelle Luscan, Ingrid Laurendeau, Valérie Malan, et al.
Genes|November 11, 2022
Noninvasive Prenatal Screening for Trisomy 21 in Patients with a Vanishing TwinPascale Kleinfinger, Armelle Luscan, Léa Descourvieres, et al.
European Journal of Human Genetics : EJHG|July 31, 2014
Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations?Eric Pasmant, Béatrice Parfait, Armelle Luscan, et al.
Human Mutation|August 6, 2013
NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experienceAudrey Sabbagh, Eric Pasmant, Apolline Imbard, et al.
Pageof 3